M&T BANK CORP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 121 filers reported holding TRANSMEDICS GROUP INC in Q4 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$472,163
-10.1%
8,623
+37.9%
0.00%0.0%
Q2 2023$525,309
+28.8%
6,255
+16.3%
0.00%0.0%
Q1 2023$407,714
-79.3%
5,380
-56.2%
0.00%
-50.0%
Q4 2022$1,966,755
+455.6%
12,280
+44.5%
0.00%
+100.0%
Q3 2022$354,000
-65.4%
8,498
-72.5%
0.00%
-60.0%
Q3 2021$1,022,000
-8.1%
30,900
-7.8%
0.01%0.0%
Q2 2021$1,112,000
+34.0%
33,506
+67.5%
0.01%
+25.0%
Q1 2021$830,00020,0060.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2021
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders